Search Results 1011-1020 of 18560 for Prednisone

1. A Study to Evaluate the Safety and Effectiveness of IFX-1 in Add-on to Standard of Care in Patients with Granulomatosis with Polyangiitis (GPA) and Microscopic Polyangiitis (MPA) - Mayo Clinic

   Received an oral daily dose of a GC of more than 10 mg prednisone-equivalent for more than 6 weeks continuously prior to screening. Received CD20 inhibitor ...

2. Cyclobenzaprine (oral route) - Mayo Clinic

   It helps relieve pain, stiffness, and discomfort caused by strains, sprains, or injuries to your muscles. However, this medicine does not take the place of rest ...

3. GPS Compared With BAT in AML CR2/CR2p - Mayo Clinic

   Has a diagnosis of immunodeficiency or is receiving chronic systemic steroid therapy (in dosing exceeding 10 mg daily of prednisone equivalent) or any other ...

4. Betamethasone sodium phosphate and betamethasone acetate (injection route) - Side effects & uses - Mayo Clinic

   Tell your doctor if you have ever had any unusual or allergic reaction to this medicine or any other medicines. Also tell your health care professional if you ...

5. A Study to Evaluate the Safety, Tolerance and Anti-tumor Activity of SAR442257 in Patients with Relapsed/Refractory Multiple Myeloma and Relapsed/Refractory Non-Hodgkin Lymphoma - Mayo Clinic

   ... prednisone 10 mg daily. Clinically-not controlled chronic or ongoing infectious disease requiring treatment at the time of first dose or within the 14 days ...

6. A Study to Test Whether Nerandomilast Helps People With Lungfibrosis Related to Rheumatic Diseases - Mayo Clinic

   If using prednisone, participants must be on stable dose for ≥4 weeks prior to Visit 2; If using rituximab, participants must have completed their first ...

7. A Study of Oral Ozanimod as Induction Therapy for Moderately to Severely Active Crohn's Disease - Mayo Clinic

   prednisone (doses ≤ 20 mg per day) or equivalent with a stable dose for at least 2 weeks prior to Screening endoscopy;; budesonide therapy (doses ≤ 9 mg ...

8. Bone Marrow-Derived Mesenchymal Stem Cell Therapy for Chronic Kidney Disease - Mayo Clinic

   Active immunosuppression therapy (including prednisone greater than or equal to 10 mg daily) 12. Kidney transplantation history 13. Solid organ ...

9. A Study to Assess the Safety and Pharmacokinetics of GDC-8264 in Combination With Standard of Care in Participants With Acute Graft-Versus-Host Disease (aGVHD) - Mayo Clinic

   Initiation of treatment with systemic corticosteroids for aGVHD at a dose of prednisone ≥ 2 milligrams per kilograms per day (mg/kg/day) by orally (PO) or ...

10. A Study To Assess Efficacy And Safety Of Pembrolizumab With Or Without Sacituzumab Tirumotecan (MK- 2870) In Adult Participants With Resectable Non Small Cell Lung Cancer (NSCLC) Not Achieving Pathological Complete Response (pCR) (MK-2870-019) - Mayo Clinic

    ... prednisone equivalent) or any other form of immunosuppressive therapy within 7 days prior the first dose of study medication * Has a known additional ...